NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Index- P/E12.28 EPS (ttm)25.06 Insider Own2.48% Shs Outstand45.07M Perf Week0.75%
Market Cap13.88B Forward P/E10.45 EPS next Y29.43 Insider Trans-19.58% Shs Float43.99M Perf Month3.79%
Income1.21B PEG1.89 EPS next Q7.31 Inst Own99.60% Short Float4.47% Perf Quarter-14.11%
Sales2.99B P/S4.63 EPS this Y13.05% Inst Trans0.35% Short Ratio3.79 Perf Half Y-14.71%
Book/sh151.02 P/B2.04 EPS next Y5.64% ROA17.01% Short Interest1.97M Perf Year11.80%
Cash/sh73.63 P/C4.18 EPS next 5Y6.49% ROE19.94% 52W Range264.33 - 417.82 Perf YTD-12.81%
Dividend Est.- P/FCF12.33 EPS past 5Y- ROI17.79% 52W High-26.37% Beta0.57
Dividend TTM- Quick Ratio5.23 Sales past 5Y14.94% Gross Margin89.00% 52W Low16.39% ATR (14)9.38
Dividend Ex-Date- Current Ratio5.46 EPS Y/Y TTM21.16% Oper. Margin46.88% RSI (14)54.36 Volatility0.81% 1.78%
Employees1305 Debt/Eq0.03 Sales Y/Y TTM19.85% Profit Margin40.44% Recom1.80 Target Price401.80
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q7.47% Payout0.00% Rel Volume0.52 Prev Close308.72
Sales Surprise8.92% EPS Surprise-0.99% Sales Q/Q17.22% EarningsApr 30 BMO Avg Volume519.30K Price307.65
SMA201.40% SMA502.08% SMA200-10.21% Trades Volume269,594 Change-0.35%
Date Action Analyst Rating Change Price Target Change
Apr-25-25Downgrade Wells Fargo Overweight → Equal Weight
Apr-21-25Upgrade BofA Securities Underperform → Neutral $314
Jul-11-24Downgrade Morgan Stanley Overweight → Equal-Weight $310 → $321
Feb-12-24Upgrade Goldman Sell → Neutral $213 → $215
Feb-05-24Initiated Leerink Partners Outperform $330
Dec-08-23Initiated Wells Fargo Overweight $309
Dec-06-22Initiated UBS Buy $320
Dec-05-22Initiated Goldman Sell $230
Oct-11-22Initiated Morgan Stanley Overweight $288
Sep-20-22Reiterated BofA Securities Underperform
May-11-25 05:01PM
May-09-25 03:21AM
12:01AM
May-07-25 12:33AM
May-05-25 04:06PM
07:15AM Loading…
May-02-25 07:15AM
May-01-25 07:57AM
03:10AM
12:37AM
12:34AM
Apr-30-25 01:09PM
09:30AM
07:35AM
06:35AM
06:30AM
03:10AM Loading…
Apr-29-25 03:10AM
Apr-28-25 10:00AM
Apr-23-25 10:01AM
Apr-22-25 03:27AM
Apr-21-25 07:00AM
Apr-16-25 07:00AM
Apr-11-25 09:40AM
08:50AM
Apr-10-25 08:50AM
Apr-08-25 12:10PM
Apr-07-25 06:38AM
05:11AM
Apr-04-25 07:00AM
Apr-02-25 12:00PM
09:47AM
08:17AM Loading…
Mar-29-25 08:17AM
Mar-28-25 06:48PM
11:30AM
05:10AM
Mar-21-25 04:47PM
Mar-18-25 09:01AM
Mar-14-25 12:11PM
Mar-12-25 12:44PM
Mar-04-25 07:00AM
Feb-28-25 11:35AM
Feb-27-25 02:11AM
Feb-26-25 11:35PM
01:31PM
09:30AM
07:57AM
07:35AM
06:48AM
06:30AM
Feb-25-25 08:03AM
Feb-24-25 09:16AM
07:00AM
Feb-23-25 01:22PM
Feb-19-25 07:00AM
Feb-14-25 04:05AM
Feb-13-25 10:13AM
Feb-12-25 06:20AM
Feb-04-25 07:00AM
Feb-03-25 05:19PM
07:00AM
Jan-28-25 03:00PM
Jan-21-25 07:00AM
Jan-10-25 09:45AM
Jan-09-25 09:40AM
09:40AM
Jan-06-25 07:00AM
Dec-28-24 04:36PM
Dec-25-24 09:45AM
Dec-24-24 11:50AM
Dec-23-24 09:40AM
08:38AM
Dec-17-24 07:00AM
Nov-29-24 11:32AM
Nov-05-24 04:30PM
09:45AM
Nov-04-24 09:40AM
Oct-31-24 04:46PM
03:08AM
01:11AM
12:10AM
Oct-30-24 09:30AM
07:40AM
06:37AM
06:30AM
Oct-29-24 09:15AM
Oct-23-24 07:00AM
06:30AM
Oct-18-24 10:51AM
Oct-16-24 05:01PM
Oct-09-24 03:31PM
07:56AM
Oct-03-24 07:36AM
Sep-24-24 07:00AM
Sep-21-24 09:22AM
Sep-10-24 07:00AM
Aug-30-24 12:02PM
11:31AM
Aug-28-24 07:00AM
Aug-22-24 07:01PM
Aug-21-24 07:08PM
Aug-20-24 06:33AM
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAHON PAUL AEVP & GENERAL COUNSELMay 15 '25Option Exercise117.7611,0001,295,36047,781May 20 04:32 PM
MAHON PAUL AEVP & GENERAL COUNSELMay 15 '25Sale295.1011,0003,246,15036,781May 20 04:32 PM
PAUL MAHONOfficerMay 15 '25Proposed Sale295.1011,0003,246,150May 15 04:04 PM
Thompson Tommy GDirectorMay 09 '25Option Exercise175.432,500438,57510,980May 12 04:30 PM
Thompson Tommy GDirectorMay 09 '25Sale305.152,500762,8658,480May 12 04:30 PM
TOMMY THOMPSONDirectorMay 09 '25Proposed Sale305.152,500762,865May 09 04:59 PM
MAHON PAUL AEVP & GENERAL COUNSELMay 01 '25Option Exercise117.7611,0001,295,36047,781May 02 04:31 PM
MAHON PAUL AEVP & GENERAL COUNSELMay 01 '25Sale300.9311,0003,310,20136,781May 02 04:31 PM
PAUL MAHONOfficerMay 01 '25Proposed Sale300.9311,0003,310,200May 01 04:04 PM
DWEK RAYMONDDirectorApr 21 '25Option Exercise175.433,000526,2904,750Apr 22 04:30 PM
DWEK RAYMONDDirectorApr 21 '25Sale285.573,000856,7101,750Apr 22 04:30 PM
RAYMOND DWEKOfficerApr 21 '25Proposed Sale285.573,000856,710Apr 21 04:00 PM
MAHON PAUL AEVP & GENERAL COUNSELApr 17 '25Option Exercise117.7611,0001,295,36047,781Apr 18 04:31 PM
MAHON PAUL AEVP & GENERAL COUNSELApr 17 '25Sale283.7811,0003,121,54336,781Apr 18 04:31 PM
PAUL MAHONOfficerApr 17 '25Proposed Sale283.7811,0003,121,543Apr 17 04:00 PM
DWEK RAYMONDDirectorApr 14 '25Option Exercise175.433,000526,2904,750Apr 15 04:28 PM
DWEK RAYMONDDirectorApr 14 '25Sale285.163,000855,4801,750Apr 15 04:28 PM
RAYMOND DWEKDirectorApr 14 '25Proposed Sale285.163,000855,480Apr 14 04:02 PM
DWEK RAYMONDDirectorApr 07 '25Option Exercise175.434,000701,7205,750Apr 08 04:30 PM
DWEK RAYMONDDirectorApr 07 '25Sale284.554,0001,138,2001,750Apr 08 04:30 PM
RAYMOND DWEKDirectorApr 07 '25Proposed Sale284.554,0001,138,200Apr 07 04:01 PM
MAHON PAUL AEVP & GENERAL COUNSELApr 03 '25Option Exercise117.7611,0001,295,36047,781Apr 07 09:05 AM
MAHON PAUL AEVP & GENERAL COUNSELApr 03 '25Sale306.1811,0003,367,98436,781Apr 07 09:05 AM
PAUL MAHONOfficerApr 03 '25Proposed Sale306.1811,0003,367,983Apr 03 04:01 PM
Thompson Tommy GDirectorMar 24 '25Option Exercise175.432,500438,57510,980Mar 25 04:31 PM
Thompson Tommy GDirectorMar 24 '25Sale318.802,500796,9908,480Mar 25 04:31 PM
TOMMY THOMPSONDirectorMar 24 '25Proposed Sale318.802,500796,990Mar 24 04:47 PM
PATUSKY CHRISTOPHERDirectorMar 19 '25Option Exercise175.435,000877,1505,900Mar 20 06:11 PM
PATUSKY CHRISTOPHERDirectorMar 19 '25Sale310.725,0001,553,585900Mar 20 06:11 PM
CHRISTOPHER PATUSKYDirectorMar 19 '25Proposed Sale310.725,0001,553,584Mar 19 04:11 PM
BENKOWITZ MICHAELPRESIDENT AND COOMar 10 '25Option Exercise111.002,000222,0002,000Mar 11 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOMar 10 '25Sale320.092,000640,1840Mar 11 04:30 PM
Michael BenkowitzOfficerMar 10 '25Proposed Sale315.911,679530,413Mar 10 04:23 PM
MAHON PAUL AEVP & GENERAL COUNSELMar 06 '25Option Exercise163.306,5501,069,61543,331Mar 07 04:33 PM
BENKOWITZ MICHAELPRESIDENT AND COOMar 03 '25Option Exercise111.009,6791,074,3697,179Mar 04 04:41 PM
BENKOWITZ MICHAELPRESIDENT AND COOMar 03 '25Sale311.999,6793,019,7360Mar 04 04:41 PM
KURZWEIL RAYDirectorFeb 28 '25Option Exercise175.4315,0002,631,45027,080Mar 03 04:31 PM
KURZWEIL RAYDirectorFeb 28 '25Sale317.0115,0004,755,15112,080Mar 03 04:31 PM
Thompson Tommy GDirectorFeb 28 '25Option Exercise175.432,500438,57510,980Mar 03 04:30 PM
Thompson Tommy GDirectorFeb 28 '25Sale318.342,500795,8388,480Mar 03 04:30 PM
TOMMY THOMPSONDirectorFeb 28 '25Proposed Sale318.342,500795,838Feb 28 04:34 PM
RAYMOND KURZWEILDirectorFeb 28 '25Proposed Sale317.0115,0004,755,152Feb 28 04:26 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 24 '25Option Exercise111.0010,0001,110,0007,500Feb 25 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 24 '25Sale360.7610,0003,607,5550Feb 25 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 20 '25Option Exercise163.307,7001,257,41044,410Feb 21 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 18 '25Option Exercise111.0010,0001,110,0007,500Feb 19 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 18 '25Sale371.0510,0003,710,4990Feb 19 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 10 '25Option Exercise111.0010,0001,110,0007,500Feb 11 04:32 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 10 '25Sale348.0610,0003,480,6420Feb 11 04:32 PM
MAHON PAUL AEVP & GENERAL COUNSELFeb 06 '25Option Exercise163.307,7001,257,41044,410Feb 10 04:30 PM
Michael BenkowitzOfficerFeb 10 '25Proposed Sale347.7140,00013,908,400Feb 10 04:28 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 03 '25Option Exercise111.0010,0001,110,0007,500Feb 04 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOFeb 03 '25Sale353.6410,0003,536,3980Feb 04 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 27 '25Option Exercise111.0010,0001,110,0007,500Jan 28 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 27 '25Sale370.7110,0003,707,0810Jan 28 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 21 '25Option Exercise111.0010,0001,110,0007,500Jan 22 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 21 '25Sale364.9110,0003,649,1120Jan 22 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 16 '25Option Exercise163.307,7001,257,41044,410Jan 17 04:31 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 13 '25Option Exercise111.0010,0001,110,0007,500Jan 14 04:31 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 13 '25Sale364.6210,0003,646,2230Jan 14 04:31 PM
PATUSKY CHRISTOPHERDirectorJan 10 '25Option Exercise175.435,000877,1505,900Jan 13 04:30 PM
PATUSKY CHRISTOPHERDirectorJan 10 '25Sale361.615,0001,808,072900Jan 13 04:30 PM
Michael BenkowitzOfficerJan 13 '25Proposed Sale364.9740,00014,598,800Jan 13 04:30 PM
CHRISTOPHER PATUSKYDirectorJan 10 '25Proposed Sale361.615,0001,808,072Jan 10 04:29 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 06 '25Option Exercise111.0010,0001,110,0007,500Jan 07 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COOJan 06 '25Sale355.1510,0003,551,5170Jan 07 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELJan 02 '25Option Exercise163.307,7001,257,41044,410Jan 03 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 30 '24Option Exercise111.0010,0001,110,0007,500Dec 31 04:32 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 30 '24Sale356.6810,0003,566,8000Dec 31 04:32 PM
Mesa NildaDirectorDec 30 '24Sale355.7725590,7205,528Dec 31 04:31 PM
NILDA MESADirectorDec 30 '24Proposed Sale355.7725590,720Dec 30 04:08 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 23 '24Option Exercise111.0010,0001,110,0007,500Dec 26 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 23 '24Sale361.9510,0003,619,5350Dec 26 04:30 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 19 '24Option Exercise163.307,7001,257,41044,410Dec 20 04:31 PM
SULLIVAN LOUIS WDirectorDec 18 '24Option Exercise175.4315,0002,631,45031,260Dec 19 04:30 PM
SULLIVAN LOUIS WDirectorDec 18 '24Sale373.2226,2099,781,7155,051Dec 19 04:30 PM
LOUIS W. SULLIVANDirectorDec 18 '24Proposed Sale373.2826,2099,783,214Dec 18 05:51 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 16 '24Option Exercise111.0010,0001,110,0007,500Dec 17 04:31 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 16 '24Sale370.1410,0003,701,3770Dec 17 04:31 PM
Michael BenkowitzOfficerDec 16 '24Proposed Sale361.8140,00014,472,400Dec 16 04:38 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 09 '24Option Exercise107.0010,0001,069,9954,500Dec 10 04:32 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 09 '24Sale367.6910,0003,676,8770Dec 10 04:32 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 05 '24Option Exercise163.307,7001,257,41044,410Dec 06 04:31 PM
MAHON PAUL AEVP & GENERAL COUNSELDec 05 '24Sale374.377,7002,882,64936,710Dec 06 04:31 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 02 '24Option Exercise104.3310,0001,043,3257,500Dec 03 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COODec 02 '24Sale370.5110,0003,705,0740Dec 03 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 25 '24Option Exercise104.3310,0001,043,3257,500Nov 27 06:44 AM
BENKOWITZ MICHAELPRESIDENT AND COONov 25 '24Sale372.7510,0003,727,5470Nov 27 06:44 AM
MAHON PAUL AEVP & GENERAL COUNSELNov 21 '24Option Exercise163.307,7001,257,41044,410Nov 22 05:37 PM
MAHON PAUL AEVP & GENERAL COUNSELNov 21 '24Sale367.367,7002,828,67236,710Nov 22 05:37 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 18 '24Option Exercise104.3310,0001,043,3257,500Nov 19 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 18 '24Sale359.2110,0003,592,0710Nov 19 04:30 PM
Michael BenkowitzOfficerNov 18 '24Proposed Sale363.2540,00014,530,000Nov 18 05:04 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 11 '24Option Exercise104.3315,0001,564,98811,250Nov 12 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 11 '24Sale407.3215,0006,109,8410Nov 12 04:30 PM
Olian Judy D.DirectorNov 11 '24Sale412.481,750721,8405,655Nov 12 04:30 PM
Mesa NildaDirectorNov 08 '24Sale412.2822492,3505,783Nov 12 04:30 PM
JUDY OLIANDirectorNov 11 '24Proposed Sale412.481,750721,840Nov 12 11:32 AM
MAHON PAUL AEVP & GENERAL COUNSELNov 07 '24Option Exercise163.307,7001,257,41044,410Nov 08 04:30 PM
BENKOWITZ MICHAELPRESIDENT AND COONov 07 '24Option Exercise104.3315,0001,564,98811,250Nov 08 04:30 PM
DOC Healthpeak Properties Inc daily Stock Chart
IndexS&P 500 P/E42.44 EPS (ttm)0.40 Insider Own0.40% Shs Outstand699.49M Perf Week-5.02%
Market Cap11.97B Forward P/E51.54 EPS next Y0.33 Insider Trans1.76% Shs Float691.95M Perf Month-10.47%
Income278.27M PEG- EPS next Q0.06 Inst Own97.03% Short Float2.16% Perf Quarter-15.08%
Sales2.80B P/S4.28 EPS this Y-30.39% Inst Trans1.20% Short Ratio2.56 Perf Half Y-21.31%
Book/sh11.71 P/B1.44 EPS next Y30.37% ROA1.38% Short Interest14.93M Perf Year-13.79%
Cash/sh0.20 P/C86.35 EPS next 5Y-1.01% ROE3.26% 52W Range16.64 - 23.13 Perf YTD-16.92%
Dividend Est.1.23 (7.29%) P/FCF10.89 EPS past 5Y52.84% ROI1.64% 52W High-27.20% Beta1.03
Dividend TTM0.87 (5.15%) Quick Ratio- Sales past 5Y17.25% Gross Margin20.95% 52W Low1.23% ATR (14)0.42
Dividend Ex-DateJun 16, 2025 Current Ratio- EPS Y/Y TTM12.82% Oper. Margin17.51% RSI (14)34.12 Volatility1.83% 1.36%
Employees387 Debt/Eq1.12 Sales Y/Y TTM23.65% Profit Margin9.95% Recom1.53 Target Price23.07
Option/ShortYes / Yes LT Debt/Eq1.07 EPS Q/Q461.11% Payout334.63% Rel Volume1.01 Prev Close16.82
Sales Surprise2.88% EPS Surprise10.70% Sales Q/Q15.88% EarningsApr 24 AMC Avg Volume5.83M Price16.84
SMA20-3.38% SMA50-9.37% SMA200-18.22% Trades Volume5,878,080 Change0.12%
Date Action Analyst Rating Change Price Target Change
Jan-15-25Upgrade Morgan Stanley Equal-Weight → Overweight $25
Oct-21-24Upgrade Deutsche Bank Hold → Buy $20 → $28
May-03-24Upgrade Wedbush Neutral → Outperform
Apr-26-24Upgrade Exane BNP Paribas Neutral → Outperform $19 → $21
Apr-22-24Resumed Mizuho Buy $22
Apr-01-24Upgrade BofA Securities Underperform → Buy $18 → $25
Mar-25-24Resumed Wells Fargo Equal Weight $19
Mar-08-24Resumed RBC Capital Mkts Outperform $21
Jan-05-24Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-26-23Initiated JMP Securities Mkt Outperform $15.50
Today 03:20PM
May-20-25 03:04AM
May-19-25 02:05PM
May-17-25 05:27AM
May-14-25 05:27AM
09:40AM Loading…
May-13-25 09:40AM
May-07-25 10:37AM
08:00AM
May-04-25 05:56PM
May-03-25 08:05AM
May-01-25 02:00PM
10:25AM
Apr-30-25 07:59PM
Apr-29-25 01:11PM
12:23PM
09:35AM Loading…
09:35AM
Apr-25-25 03:19PM
01:40PM
06:46AM
Apr-24-25 06:00PM
05:30PM
04:17PM
04:16PM
04:15PM
Apr-23-25 08:50AM
Apr-21-25 12:27PM
09:15AM
Apr-20-25 07:00AM
Apr-13-25 09:00AM
Apr-10-25 10:45AM
08:52AM Loading…
08:52AM
Apr-07-25 07:18PM
04:15PM
07:00AM
06:45AM
Apr-03-25 04:15PM
08:50AM
Mar-31-25 11:35AM
10:30AM
Mar-27-25 04:47PM
Mar-10-25 03:02PM
Feb-11-25 01:47PM
Feb-05-25 05:32PM
Feb-04-25 01:32PM
Feb-03-25 04:15PM
Jan-15-25 04:15PM
Jan-07-25 04:15PM
Jan-02-25 10:40AM
Dec-18-24 09:50PM
Dec-11-24 07:30AM
Dec-09-24 04:15PM
Dec-01-24 06:19PM
Nov-18-24 04:15PM
Nov-13-24 02:30PM
Nov-04-24 08:00AM
Oct-26-24 03:07AM
Oct-25-24 02:46PM
Oct-24-24 04:15PM
Sep-27-24 05:07PM
Sep-26-24 04:15PM
Sep-13-24 12:15PM
Sep-11-24 12:10PM
Aug-23-24 07:14PM
Aug-19-24 12:00PM
Jul-26-24 11:04AM
Jul-25-24 04:15PM
Jul-22-24 02:00PM
Jul-12-24 09:22AM
Jun-27-24 03:52PM
Jun-24-24 05:43PM
Jun-20-24 04:15PM
Jun-19-24 06:45AM
Jun-13-24 04:15PM
May-30-24 04:15PM
May-07-24 04:15PM
Apr-27-24 03:07AM
01:05AM
Apr-26-24 04:07PM
Apr-25-24 04:15PM
Apr-04-24 04:15PM
Mar-04-24 02:06PM
Feb-26-24 06:04PM
04:15PM
Feb-21-24 08:00PM
07:10PM
06:18PM
05:33PM
05:00PM
05:00PM
Feb-12-24 08:28AM
Feb-10-24 08:32AM
Jan-27-24 12:07PM
Jan-26-24 12:12PM
Jan-09-24 04:02PM
Jan-01-24 11:03AM
Dec-21-23 07:00AM
Nov-09-23 09:44AM
06:14AM
Nov-07-23 01:52PM
Nov-02-23 06:23AM
Healthpeak Properties, Inc. is a Standard & Poor's 500 company, which engages in acquiring, developing, owning, leasing, and managing healthcare real estate across the United States. It operates through the following segments: Lab, Outpatient Medical, Continuing Care Retirement Community (CCRC), and Other Non-Reportable. The Lab segment refers to lab properties, which contain laboratory and office space. The Outpatient Medical segment includes outpatient medical buildings and hospitals. The CCRC segment deals with retirement communities that include independent living, assisted living, memory care, and skilled nursing units. The Other Non-Reportable segment consists of an unconsolidated joint venture with a sovereign wealth fund that owns 19 senior housing assets and loans receivable. The company was founded in 1985 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Tommy GDirectorMay 09 '25Buy17.365,70098,974138,513May 12 12:02 PM
Brinker Scott MPresident and CEOMay 09 '25Buy17.392,75047,822204,613May 12 12:01 PM
Lias-Booker AvaDirectorApr 29 '25Buy17.835,00089,15035,561Apr 29 05:06 PM
Thomas John TDirectorApr 28 '25Buy17.844,20074,928813,566Apr 28 05:56 PM
Sandstrom Katherine MDirectorApr 28 '25Buy17.6511,288199,23356,268Apr 28 05:54 PM
Lewis Sara GrootwassinkDirectorApr 28 '25Buy17.666,000105,9389,000Apr 28 05:52 PM
SHELLEY-KESSLER PAMELADirectorApr 28 '25Buy17.612,83849,9913,965Apr 28 05:51 PM
Brinker Scott MPresident and CEOApr 28 '25Buy17.6811,337200,438201,863Apr 28 05:49 PM
TXMD TherapeuticsMD Inc daily Stock Chart
Index- P/E- EPS (ttm)-0.18 Insider Own2.03% Shs Outstand11.57M Perf Week-3.33%
Market Cap16.78M Forward P/E- EPS next Y- Insider Trans1.35% Shs Float11.34M Perf Month27.19%
Income-2.10M PEG- EPS next Q- Inst Own28.90% Short Float1.04% Perf Quarter45.00%
Sales1.84M P/S9.12 EPS this Y- Inst Trans-10.87% Short Ratio1.74 Perf Half Y11.54%
Book/sh2.31 P/B0.63 EPS next Y- ROA-5.33% Short Interest0.12M Perf Year-30.62%
Cash/sh0.50 P/C2.92 EPS next 5Y- ROE-7.72% 52W Range0.70 - 2.44 Perf YTD68.60%
Dividend Est.- P/FCF11.90 EPS past 5Y64.95% ROI-6.42% 52W High-40.57% Beta0.63
Dividend TTM- Quick Ratio2.15 Sales past 5Y498.17% Gross Margin74.42% 52W Low107.14% ATR (14)0.09
Dividend Ex-Date- Current Ratio2.15 EPS Y/Y TTM73.70% Oper. Margin-170.18% RSI (14)64.28 Volatility1.16% 3.31%
Employees1 Debt/Eq0.26 Sales Y/Y TTM53.54% Profit Margin-114.07% Recom3.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q11.16% Payout- Rel Volume0.21 Prev Close1.45
Sales Surprise- EPS Surprise- Sales Q/Q25.56% EarningsMay 13 AMC Avg Volume67.76K Price1.45
SMA202.37% SMA5027.69% SMA20010.69% Trades Volume14,087 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-07-20Downgrade Jefferies Hold → Underperform
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
May-13-25 05:02PM
04:05PM
Mar-27-25 04:05PM
Nov-12-24 04:32PM
04:05PM
05:26PM Loading…
Aug-12-24 05:26PM
04:05PM
Jun-28-24 11:52AM
May-10-24 08:53PM
04:43PM
04:05PM
Mar-29-24 04:00PM
Mar-12-24 11:40AM
Jan-30-24 11:20PM
Nov-15-23 05:08AM
04:05PM Loading…
Nov-14-23 04:05PM
Aug-14-23 07:52AM
06:50AM
May-15-23 05:56PM
04:05PM
Apr-14-23 12:00PM
Apr-07-23 04:01PM
Jan-03-23 06:50AM
Dec-08-22 10:42AM
Dec-04-22 06:00PM
Nov-14-22 07:55PM
04:05PM
Oct-31-22 06:50AM
Oct-03-22 01:45PM
06:50AM
06:50AM Loading…
Sep-12-22 06:50AM
Aug-15-22 01:00PM
08:05AM
06:50AM
Aug-08-22 06:50AM
Aug-01-22 01:00PM
06:50AM
Jul-15-22 01:34PM
Jul-13-22 09:48AM
08:25AM
06:50AM
Jul-06-22 06:09AM
Jun-06-22 04:05PM
May-31-22 06:00AM
May-20-22 10:52AM
09:43AM
May-16-22 08:00PM
05:45PM
04:05PM
May-12-22 05:25PM
May-10-22 04:05PM
Apr-14-22 04:15PM
Mar-10-22 01:30PM
08:05AM
06:50AM
Mar-07-22 12:57PM
07:40AM
Mar-01-22 04:30PM
Feb-28-22 05:35PM
Feb-24-22 09:05AM
Jan-25-22 08:52AM
Jan-06-22 07:29AM
Jan-04-22 06:20AM
Dec-28-21 09:53AM
Dec-13-21 06:08AM
Dec-10-21 04:30PM
Dec-08-21 06:50AM
Nov-24-21 07:54AM
Nov-22-21 10:40AM
Nov-12-21 03:00AM
Nov-11-21 06:50AM
06:45AM
Nov-04-21 03:01PM
Oct-27-21 05:00PM
Oct-15-21 05:33PM
Oct-05-21 01:28PM
Oct-04-21 09:20AM
Sep-02-21 06:50AM
Aug-23-21 06:50AM
Aug-19-21 08:01AM
Aug-09-21 04:30PM
Aug-04-21 08:05AM
06:50AM
Jul-28-21 03:03PM
Jul-26-21 06:50AM
Jul-06-21 11:49AM
Jun-29-21 08:58AM
May-25-21 06:50AM
May-24-21 07:00AM
May-07-21 01:31AM
May-06-21 10:56AM
08:20AM
07:00AM
06:45AM
May-03-21 07:00AM
Apr-29-21 10:34AM
07:00AM
Apr-28-21 12:34PM
Apr-09-21 11:16AM
05:05AM
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson Tommy GDirectorApr 14 '25Buy1.0032532614,779Apr 15 07:59 AM
Walker Marlan DChief Executive OfficerApr 14 '25Buy1.0049048973,639Apr 15 07:59 AM
Walker Marlan DChief Executive OfficerApr 10 '25Buy0.861,1671,00073,149Apr 10 04:29 PM
Walker Marlan DChief Executive OfficerApr 09 '25Buy0.871,13699471,982Apr 10 04:29 PM
Collins Cooper C.DirectorFeb 18 '25Option Exercise0.008,500060,516Feb 20 09:08 PM
Naughton Gail KDirectorFeb 18 '25Option Exercise0.008,50008,500Feb 20 09:07 PM
Thompson Tommy GDirectorFeb 18 '25Option Exercise0.008,500014,454Feb 20 09:07 PM
Walker Marlan DChief Executive OfficerFeb 18 '25Option Exercise0.008,281070,846Feb 20 09:07 PM
Collins Cooper C.DirectorAug 22 '24Buy1.734,0947,09952,016Aug 26 05:40 PM
Collins Cooper C.DirectorAug 21 '24Buy1.701,2002,03947,922Aug 23 06:18 PM